Page images
PDF
EPUB

488-2722. The standard application forms, as furnished by CDC, must be used for this program.

Award Procedure:

After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public.

Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

From 90 to 120 days. From three to six months.

Appeals:

Not Applicable.

Renewals:

Project periods are for one to five years with 12-month budget periods.

Formula and Matching Requirements:

This program has no statutory formula.

Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance:

The project period on these grants is one to five years and the budget period is 12 months. Method of awarding/releasing assistance: by letter of credit. Reports:

See FOA for details. Cash reports are not applicable. See FOA for details. No expenditure reports are required. See FOA for detsails. Audits:

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.

Records:

Financial records, supporting documents, statistical records, and all other records pertinent to the project shall be retained for at least 3 years or until resolution of any audit questions. Property records must be retained in accordance with PHS Grants Policy Statement requirements. Account Identification:

75-0943-0-1-550.

Obligations:

(Cooperative Agreements (Discretionary Grants)) FY 08 not reported.; FY 09
est not reported.; FY 10 est not reported. - FY08 - $333,899,889; FY09 - est
$340,455,348; FY10 - est $340,455,348.

Note: 93.940 includes funds appropriated by congress for HIV testing.
Range and Average of Financial Assistance:

No Data Available.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

Regulations governing this program are published under 42 CFR Part 51.
Guidelines are available in the application kit. PHS Grants Policy Statement
No. 94-50,000 (Revised) April 1, 1994.
Regional or Local Office:

None.

Headquarters Office:

Reginald Carsonn, 1600 Clifton Road, NE, Mailstop E-07, Atlanta, Georgia 30333 Email: rdc2@cdc.gov Phone: (404) 639-0022.

Website Address:

http://www.cdc.gov.

RELATED PROGRAMS:

93.118 Acquired Immunodeficiency Syndrome (AIDS) Activity; 93.283 Centers for Disease Control and Prevention_Investigations and Technical Assistance; 93.991 Preventive Health and Health Services Block Grant EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Applications will be evaluated based on (1) satisfactory progress in meeting project objectives; (2) the extent to which the objectives for the new budget period are specific; (3) measurable, time phased, realistic, and consistent with National HIV Prevention Goals; (3) the extent to which proposed changes in methods of operation are appropriate and likely to improve prevention efforts; (4) evaluation plans which enhance the success of the project; (5) the availability of funds.

93.941 HIV DEMONSTRATION, RESEARCH, PUBLIC AND PROFESSIONAL EDUCATION PROJECTS

FEDERAL AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services

AUTHORIZATION:

Public Health Service Act, Section 301(a).
OBJECTIVES:

To develop, test, and disseminate improved HIV prevention strategies.
TYPES OF ASSISTANCE:

PROJECT GRANTS

USES AND USE RESTRICTIONS:

To assist States, political subdivisions of States, and other public and nonprofit
entities with research on the prevention of HIV infection at the community
level. Funds may be used to develop, implement and evaluate new intervention,
including those targeting people who are infected with HIV. Applicants are
encouraged to have research groups participate in the program.
Applicant Eligibility:

States, political subdivisions of States, other public including American
Indian/Alaska Native tribal governments or tribal organizations located wholly
or in part within their boundaries and nonprofit private entities.
Beneficiary Eligibility:

States, political subdivisions of States, other public including American
Indian/Alaska Native tribal governments or tribal organizations located wholly
or in part within their boundaries and nonprofit private entities.
Credentials/Documentation:

Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, and provide a budget with justification of funds requested. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. For nonprofit recipients, costs will be determined in accordance with HHS Regulations 45 CFR 74, Subpart Q. This program is excluded from coverage under OMB Circular No. A-87.

Preapplication Coordination:

Preapplication coordination is required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. Application Procedures:

This program is excluded from coverage under OMB Circular No. A-102. This program is excluded from coverage under OMB Circular No. A-110. To apply for this funding opportunity, use application form PHS 398 (OMB number 0925-0001 rev. 5/2001). Forms and instructions are available in an interactive format on the CDC web site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm. Submit the signed original and five copies of your application by mail or express delivery service to: Technical Information Management, CDC Procurement and Grants Office, 2920

Brandywine Road, Atlanta, GA 30341.

Award Procedure:

After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public.

Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

From three to six months.

Appeals:

As stated in the Terms and Conditions.

Renewals:

Projects are for one to five years with 12-month budget periods. Application forms must be obtained from the Grants Management Officer, Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention: Telephone: (770) 488-2720.

Formula and Matching Requirements:

This program has no statutory formula.

Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance:

Project Period: From one to five years. Budget Period: For 12 months. Method of awarding/releasing assistance: by letter of credit.

Reports:

See FOA for details. No cash reports are required. See FOA for details. No expenditure reports are required. See FOA for details.

Audits:

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.

Records:

Financial records, supporting documents, statistical records, and all other records pertinent to the project shall be retained for at least 3 years or until resolution of any audit questions. Property records must be retained in accordance with PHS Grants Policy Statement requirements. Account Identification:

75-0943-0-1-550.

Obligations:

(Salaries) FY 08 not reported.; FY 09 est not reported.; FY 10 est not reported. FY 08 14,703,324; FY 09 est $9,910,574; FY 10 est $9,910,574. Range and Average of Financial Assistance:

No Data Available.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

Regulations governing this program are published under 42 CFR Part 51b.
Guidelines are available in the application kit. PHS Grants Policy Statement
No. 94-50,000 (Revised) April 1, 1994.
Regional or Local Office:

None.

Headquarters Office:

Reginald Carsonn, 1600 Clifton Road, NE, Mailstop E-07, Atlanta, Georgia 30333 Email: rdc2@cdc.gov Phone: (404) 639-0022. Website Address:

http://www.cdc.gov.

RELATED PROGRAMS:

93.283 Centers for Disease Control and Prevention_Investigations and

Technical Assistance; 93.978 Preventive Health Services_Sexually Transmitted Diseases Research, Demonstrations, and Public Information and Education Grants; 93.991 Preventive Health and Health Services Block Grant EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Applications will be evaluated on the extent to which proposed objectives are specific, measurable, time-phased, and consistent with the stated purpose of this program; the extent to which the applicant's proposed plan will identify and reach appropriate hard-to-reach individuals at risk for HIV, and the quality and scope of the applicant's past and current activities to provide education about HIV prevention and AIDS to high risk individuals; the quality of the applicant's proposed interventions and strategies to motivate and reinforce risk reduction behavior change among hard-to-reach individuals; the quality of the applicant's proposed plan to promote changes in community norms regarding HIV prevention and risk reduction behavior, and to generate support, cooperation, and collaboration with community based organizations serving individuals at high risk for HIV; the extent to which the applicant's proposed plan will determine, monitor, and measure changes in the prevalence of specific knowledge, attitudes, beliefs and self-reported behaviors among hard-to-reach individuals; the quality of the applicant's plan, including proposed methods and instruments of measurement to evaluate effectiveness of the strategies used to motivate and reinforce behavior change among groups targeted by the interventions, and the impact of the programmatic efforts on community norms; the extent to which the applicant's proposed plan will enable it to respond to and redirect programmatic efforts based on new information, changes in behavior, and changes in HIV sero prevalence.

93.942 RESEARCH, TREATMENT AND EDUCATION PROGRAMS ON LYME DISEASE IN THE UNITED STATES (Lyme Disease)

FEDERAL AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services

AUTHORIZATION:

Public Health Service Act, Section 301, 42 U.S.C 241(a), as amended by Public
Health Service Act, Section 317(K)(2), 42 U.S.C 247b(k)(2).
OBJECTIVES:

To develop, implement and evaluate practical and effective measures for the primary and secondary prevention of Lyme disease in the United States. TYPES OF ASSISTANCE:

Cooperative Agreements

USES AND USE RESTRICTIONS:

Funding opportunities are made available to develop disease surveillance, conduct ecological and epidemiological studies, develop prevention and control activities, develop better diagnostic tests, and develop and disseminate educational materials and programs. Grants include funds for direct costs, i.e., personnel, travel, equipment, supplies, necessary to carry out an approved project as well as funds for the reimbursement of applicable indirect costs. Unallowable costs, such as reimbursement of pre-award costs, as well as those for which prior written approval is required, are indicated in the Public Health Service (PHS) Grants Policy Statement (http://www.hhs.gov/grantsnet.gps/). Applicant Eligibility:

Public and nonprofit organizations able to provide services to geographical areas where Lyme disease is endemic or found to be newly emerging in the continental United States. Thus, universities, colleges, research institutions, State and local health departments, and private nonprofit organizations are eligible.

Beneficiary Eligibility:

States, political subdivisions of states, and other public and nonprofit private entities and the general public who may be exposed to the threat of Lyme

disease in certain geographical areas. Credentials/Documentation:

Nonprofit organizations are corporations or associations no part of whose net earnings may lawfully inure to the benefit of any private shareholder or individual. Proof of nonprofit status must be submitted by private nonprofit organizations with the application or, if previously filed with PHS, the applicant must state where and when the proof was submitted. This program is excluded from coverage under OMB Circular No. A-87.

Preapplication Coordination:

This program has no preapplication requirements. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedures:

OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. To apply for this funding opportunity, applications must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide. Detailed application instructions are included in the Funding Opportunity Announcements (FOAS) for federal assistance. Submit the signed original and five copies of your application by mail or express delivery service to: Technical Information Management System, (Add FOA number here), CDC Procurement and Grants Office, U.S. Department of Health and Human Services, 2920 Brandywine Road, Atlanta, GA 30341. This program is subject to the provisions of 45 CFR 92 for State and local governments and OMB Circular No. A-110 for nonprofit organizations.

Award Procedure:

Upon receipt, applications will be evaluated for completeness and responsiveness by the agency program and HHS/CDC Procurement and Grants Office (PGO). HHS/CDC will not review incomplete and non-responsive applications. After review and approval, a notice of grant award (NOA) is prepared and processed, along with appropriate notification to the public. Initial award provides funds for first budget period (usually 12 months) and NoA indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

Approximately three to six months.

Appeals:

Not Applicable.

Renewals:

Cooperative agreement project periods are for three to four years. Subject to availability of funds, after initial awards, projects may be renewed non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.

Formula and Matching Requirements:

This program has no statutory formula.

This program has no matching requirements.

This program does not have MOE requirements.

Length and Time Phasing of Assistance:

Assistance is available for a 12-month budget period within project periods ranging from 3 to 4 years. See the following for information on how assistance is awarded/released: After awards are issued, funds are released in accordance with the payment procedure established by the grantee institution with DHHS, which may be an Electronic Transfer System or a Monthly Cost Request System.

Reports:

Program reports are not applicable. Cash reports are not applicable. An original and two hard-copies of the Non-Competing Grant Progress Report (PHS 2590) are due no less than 120 days prior to the end of each budget period within the project period. Financial status reports are required no later than 90 days after the end of each budget period. Final financial status reports are required no more than 90 days after the end of the project period. Final performance reports are required no more than 90 days after the end of the project period. All reports must be submitted to the Grants Management Specialist indicated in the NoA. Audits:

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. Records:

Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.

Account Identification:

75-0943-0-1-550.

Obligations:

(Cooperative Agreements) FY 08 $1,400,494; FY 09 est $1,400,363; FY 10 est $1,500,000

Range and Average of Financial Assistance:

$250,000 to $901,000; Average award depends on funding opportunity

announcement.

PROGRAM ACCOMPLISHMENTS:

Fiscal Year 2008: Beginning in fiscal year 2008, two new competitive funding opportunities were announced with one cooperative agreement awarded for the evaluation of reservoir-targeted vaccine formulations to prevent enzootic transmission of Borrelia burgdorferi (Lyme Borreliosis), and two cooperative agreements awarded for field trials to evaluate efficacy of natural products for the control of the tick vectors of Lyme disease spirochetes. Fiscal Year 2009: No Current Data Available Fiscal Year 2010: No Current Data Available REGULATIONS, GUIDELINES, AND LITERATURE:

PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000 (Rev.) April 1, 1994. Pertinent information may be obtained by contacting the Headquarters Office.

Regional or Local Office:

See Regional Agency Offices. Bacterial Diseases Branch, Division of
Vector-borne Infectious Diseases, National Center for Zoonotic, Vector-borne
and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for
Disease Control and Prevention, 3150 Rampart Road, Fort Collins, CO 80521.
Branch Extramural Activities Contacts: Ms. Diane Hamm - Telephone: (970)
221-6414 and Dr. Charles B. (Ben) Beard - Telephone: (970) 221-6418.
Division Extramural Activities Contacts: Ms. Mary Ellen (Mel) Fernandez -
Telephone: (970) 221-6426. Dr. Lyle R. Petersen - Telephone: (970) 221-6428.
Headquarters Office:

Trudy Messmer, Centers for Disease Control and Prevention, CCID/SSPU
Extramural Programs, MS E60

1600 Clifton Road, N.E., Atlanta, Georgia 30333 Email: Trudy.Messmer@cdc.hhs.gov Phone: (404) 498-2271. Website Address:

http://www.cdc.gov.

RELATED PROGRAMS: Not Applicable.

EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Applications will be evaluated on the review criteria described in the Funding Opportunity Announcements (FOAS). In general, the review and selection process of complete and responsive applications to the FOA consists of determination of the scientific merit by peer review, availability of funds, and relevance of program priorities and the priorities of DHHS. Refer to the FOA for additional review criteria.

93.943 EPIDEMIOLOGIC RESEARCH STUDIES OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION IN SELECTED POPULATION GROUPS

(Epidemiologic Research Studies of AIDS and HIV)

FEDERAL AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services

AUTHORIZATION:

Public Health Act, Section 301.

OBJECTIVES:

To support research of important HIV-related epidemiologic issues concerning risks of transmission, the natural history and transmission of the disease in certain populations and development and evaluation of behavioral recommendations for reducing AIDS and HIV infection. Of special interest are programs that examine these research issues as they affect minority populations (defined as one of the four federally-recognized groups: African-Americans; Asian/Pacific Islanders; Latinos/Hispanics; and Native Americans). TYPES OF ASSISTANCE:

PROJECT GRANTS

USES AND USE RESTRICTIONS:

Assistance is provided to support cooperative agreements that examine important epidemiologic research issues concerning AIDS and HIV infection. The research should contribute to the health services knowledge base from which empirically based information can be derived by policy makers, both immediately and over the coming decades. Grants include funds for direct costs (such as personnel, travel, equipment, or supplies) necessary to carry out an approved project as well as funds for the reimbursement of applicable indirect costs. Unallowable costs, as well as those for which prior written approval is required, are indicated in the PHS Grants Policy Statement.

Applicant Eligibility:

Eligible applicants include States, political subdivisions of States or their agents or instrumentalities, private research organizations, including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, other public and private nonprofit organizations, and for-profit organizations.

Beneficiary Eligibility:

State and local health agencies; private research organizations, public and private nonprofit organizations, for profit organizations; minority groups; including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and persons physically afflicted with AIDS/HIV infection.

Credentials/Documentation:

Costs will be determined by HHS Regulations 45 CFR Part 74, Subpart Q for nonprofit organizations and in accordance with OMB Circular No. A-87, "Cost Principles for State and Local Governments.". OMB Circular No. A-87 applies to this program.

Preapplication Coordination:

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Application Procedures:

OMB Circular No. A-102 applies to this program. OMB Circular No. A-110

applies to this program. A signed original and five copies of the application Form 398 must be sent to the Centers for Disease Control and Prevention (CDC). State and local governments may use Form 5161. An original and two copies must be submitted. This program is subject to the provisions of 45 CFR 92 for State and Local Governments and 45 CFR 74 for nonprofit organizations, as appropriate.

Award Procedure:

After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public, initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. However, applicants are encouraged to call CDC for programmatic technical assistance prior to the development and submission of their assistance application.

Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

From 120 to 180 days. About 120 days from receipt of application.
Appeals:

As stated in the Terms and Conditions.
Renewals:

If additional support is desired to continue a research project beyond the approved project period, an application for competing continuation must be submitted for review in the same manner as a new application.

Formula and Matching Requirements:

This program has no statutory formula.

Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance:

Assistance is available for a 12-month budget period within project periods ranging from one to three years. After awards are issued, funds are released in accordance with the payment procedure established by the grantee institution with DHHS, which may be an Electronic Transfer System or a Monthly Cost Request System. Method of awarding/releasing assistance: by letter of credit. Reports:

See FOA for details. No cash reports are required. See FOA for details. No expenditure reports are required. See FOA for details. Audits:

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.

Records:

Financial records, supporting documents, statistical records, and all other records pertinent to the project must be kept readily available for review by personnel authorized to examine PHS grant accounts. Records must be maintained for a minimum of 3 years after the end of a budget period. If questions still remain, such as those raised as a result of an audit, records must be retained until completion or resolution of any audit in process or pending resolution. Property records must be retained in accordance with PHS Grants Policy Statement requirements.

Account Identification:

75-0943-0-1-550.

Obligations:

(Salaries) FY 08 not reported.; FY 09 est not reported.; FY 10 est not reported. FY08 - $4,416,307; FY09 - est $3,044,300; FY10 - est $3,044,300. Range and Average of Financial Assistance:

No Data Available.

PROGRAM ACCOMPLISHMENTS:

Not Applicable.

REGULATIONS, GUIDELINES, AND LITERATURE:

Regulations governing this program are published in the application kit. PHS
Grants Policy Statement No. 94-50,000 (Revised) April 1, 1994.
Regional or Local Office:

None.

Headquarters Office:

Reginald Carsonn 1600 Clifton Road, NE, Mailstop E-07, Atlanta, Georgia 30333 Email: rdc2@cdc.gov Phone: 4046390022

Website Address:

http://www.cdc.gov.

RELATED PROGRAMS:

93.118 Acquired Immunodeficiency Syndrome (AIDS) Activity EXAMPLES OF FUNDED PROJECTS:

Not Applicable.

CRITERIA FOR SELECTING PROPOSALS:

Applications will be reviewed and evaluated based on the evidence submitted which specifically describes the applicant's abilities to meet the following criteria: (1) the plans to develop and implement the study describing how study participants will be identified, enrolled, tested and followed; (2) the ability to enroll and follow an adequate number of eligible study participants to assure proper conduct of the study. This includes both demonstration of the availability of HIV-infected potential study participants and the experience of the investigator in enrolling and following such persons; (3) the applicant's current activities in AIDS and HIV research and how they will be applied to achieving the objectives of the study; letters of support from cooperating organizations that demonstrate that nature and extent of such cooperation should be included; (4) the applicant's understanding of the research study objectives and, their ability, willingness and/or need to collaborate with CDC and researchers from other study sites in study design and analysis, including use of common forms, and sharing of specimens and data; (5) the plan to protect the rights and confidentiality of all participants and ensure adequate participation; (6) the size, qualifications and time allocation of the proposed staff and the availability of facilities to be used during the research study; (7) how the project will be administered to assure the proper management of the daily activities of the program; (8) the proposed schedule for accomplishing the activities of the research; including time frames; and (9) the quality of an evaluation plan which specifies methods and instruments to be used to evaluate the progress made in attaining research objectives.

93.944 HUMAN IMMUNODEFICIENCY VIRUS (HIV)/ACQUIRED IMMUNODEFICIENCY VIRUS SYNDROME (AIDS) SURVEILLANCE

(HIV/AIDS Surveillance)

FEDERAL AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services

AUTHORIZATION:

Public Health Service Act, Section 301(a).
OBJECTIVES:

To continue and strengthen effective human immunodeficiency virus (HIV) and
acquired immunodeficiency syndrome (AIDS) surveillance programs and to
effect, maintain, measure and evaluate the extent of HIV/AIDS incidence and
prevalence throughout the United States and its territories, providing
information for targeting and implementing HIV prevention activities.
TYPES OF ASSISTANCE:

PROJECT GRANTS

USES AND USE RESTRICTIONS:

Grant funds may be used for salaries of staff conducting HIV/AIDS surveillance and sero surveillance activities, travel related to carrying out project activities and participating in national planning and implementation

meetings, necessary supplies, computer software and hardware, and laboratory, data collection, and analysis costs. Grant funds are to be additive to replace existing resources.

Applicant Eligibility:

The governments, or their agents or instrumentalities, of any of the States of the United States, the District of Columbia, the Commonwealth of Puerto Rico, territories or possessions of United States, including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and local governments who are current recipients of HIV/AIDS surveillance cooperative agreements.

Beneficiary Eligibility:

Official health agencies will benefit. Credentials/Documentation:

Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. This program is excluded from coverage under OMB Circular No. A-87.

Preapplication Coordination:

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.

Application Procedures:

This program is excluded from coverage under OMB Circular No. A-102. This program is excluded from coverage under OMB Circular No. A-110. Applications are made in the form of an application PHS-5161-1, to the Centers for Disease Control and Prevention. The standard application forms, as furnished by PHS and required by 45 CFR 92 for State and local governments must be used for this program. This program is subject to the provisions of 45 CFR Part 92 for State and local governments. Award Procedure:

After review and approval, a notice of award is prepared and processed, along with appropriate notification to the public. Initial award provides funds for first budget period (usually 12 months) and Notice of Award (Form 5152-1) indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. Deadlines:

Contact the headquarters or regional office, as appropriate, for application deadlines.

Range of Approval/Disapproval Time:

From 120 to 180 days. About 120 days after application submission.
Appeals:

As stated in the Terms and Conditions.
Renewals:

Renewals may be approved for one to five years.

Formula and Matching Requirements:

This program has no statutory formula.

Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.

Length and Time Phasing of Assistance:

From one to five years. Method of awarding/releasing assistance: by letter of credit.

Reports:

See FOA for details. No cash reports are required. See FOA for details. No expenditure reports are required. See FOA for details.

Audits:

In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit

« PreviousContinue »